Loading clinical trials...
Loading clinical trials...
Cognitive impairment is also a major risk factor for development of dementia later in life. Findings from the investigators studies suggest that the carotenoids, lutein and zeaxanthin may be important...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Tufts University
NCT06347315 · Mild Cognitive Impairment
NCT07652775 · Mild Cognitive Impairment (MCI), Depressive Symptoms
NCT05877196 · Mild Cognitive Impairment, Alzheimer Disease, and more
NCT07441915 · Parkinson's Disease, Mild Cognitive Impairment
NCT04240561 · Hearing Loss, Sensorineural, Dementia of Alzheimer Type, and more
Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions